Top

Published in:

Open Access 07-07-2023 | Schistosomiasis | Guideline

Schistosomiasis in non-endemic areas: Italian consensus recommendations for screening, diagnosis and management by the Italian Society of Tropical Medicine and Global Health (SIMET), endorsed by the Committee for the Study of Parasitology of the Italian Association of Clinical Microbiologists (CoSP-AMCLI), the Italian Society of Parasitology (SoIPa), the Italian Society of Gastroenterology and Digestive Endoscopy (SIGE), the Italian Society of Gynaecology and Obstetrics (SIGO), the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV), the Italian Society of General Medicine and Primary Care (SIMG), the Italian Society of Infectious and Tropical Diseases (SIMIT), the Italian Society of Pediatrics (SIP), the Italian Society of Paediatric Infectious Diseases (SITIP), the Italian Society of Urology (SIU)

Authors: Agnese Comelli, Camilla Genovese, Federico Gobbi, Gaetano Brindicci, Susanna Capone, Angela Corpolongo, Verena Crosato, Valentina Dianora Mangano, Rosalia Marrone, Maria Merelli, Marco Prato, Carmen Rita Santoro, Salvatore Scarso, Elisa Vanino, Valentina Marchese, Spinello Antinori, Claudio Mastroianni, Annibale Raglio, Fabrizio Bruschi, Andrea Minervini, Daniele Donà, Silvia Garazzino, Luisa Galli, Andrea Lo Vecchio, Andrea Galli, Gabriele Dragoni, Claudio Cricelli, Nicola Colacurci, Enrico Ferrazzi, Annalisa Pieralli, Antonio Montresor, Joachim Richter, Guido Calleri, Alessandro Bartoloni, Lorenzo Zammarchi

Published in: Infection | Issue 5/2023

Excerpt

Human schistosomiasis is a chronic parasitic disease caused by trematode worms of the genus Schistosoma. It affects people living in tropical and subtropical regions where approximately 780 million people are at risk[1]. …

Available only for authorised users

Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6:411–25. https://doi.org/10.1016/S1473-3099(06)70521-7.CrossRefPubMed

Hotez PJ, Fenwick A. Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl Trop Dis. 2009;3:e485. https://doi.org/10.1371/journal.pntd.0000485.CrossRefPubMedPubMedCentral

IOM, UN Migration. Flow monitoring. https://dtm.iom.int/content/europe-migration-arrivals-dashboard Accessed 9 Mar, 2023

Asundi A, Beliavsky A, Liu XJ, Akaberi A, Schwarzer G, Bisoffi Z, et al. Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. Lancet Glob Health. 2019;7:e236–48. https://doi.org/10.1016/S2214-109X(18)30490-X.CrossRefPubMed

Landeryou T, Rabone M, Allan F, Maddren R, Rollinson D, Webster BL, et al. Genome-wide insights into adaptive hybridisation across the Schistosoma haematobium group in West and Central Africa. PLoS Negl Trop Dis. 2022;16:e0010088. https://doi.org/10.1371/journal.pntd.0010088.CrossRefPubMedPubMedCentral

Ansart S, Perez L, Vergely O, Danis M, Bricaire F, Caumes E. Illnesses in travelers returning from the tropics: a prospective study of 622 patients. J Travel Med. 2005;12:312–8. https://doi.org/10.2310/7060.2005.12603.CrossRefPubMed

Brown BB. Delphi Process: A Methodology Used for the Elicitation of Opinions of Experts. Santa Monica, CA: RAND Corporation; 1968.

WHO. Schistosomiasis https://www.who.int/news-room/fact-sheets/detail/schistosomiasis accessed 22 Jun 2022.

Boissier J, Grech-Angelini S, Webster BL, Allienne JF, Huyse T, Mas-Coma S, et al. Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study. Lancet Infect Dis. 2016;16:971–9. https://doi.org/10.1016/S1473-3099(16)00175-4.CrossRefPubMed

10.

Salas-Coronas J, Bargues MD, Lozano-Serrano AB, Artigas P, Martínez-Ortí A, Mas-Coma S, et al. Evidence of autochthonous transmission of urinary schistosomiasis in Almeria (southeast Spain): An outbreak analysis. Travel Med Infect Dis. 2021;44:102165. https://doi.org/10.1016/j.tmaid.2021.102165.CrossRefPubMed

11.

Othman A, el Ridi R. Schistosomiasis. Helminth Infect Imp Glob Public Health. 2022. https://doi.org/10.1007/978-3-031-00303-5_5.CrossRef

12.

Leger E, Webster JP. Hybridizations within the Genus Schistosoma: Implications for evolution, epidemiology and control. Parasitology. 2017;144:65–80. https://doi.org/10.1017/S0031182016001190.CrossRefPubMed

13.

Lambertucci JR. Acute schistosomiasis mansoni: revisited and reconsidered. Mem Inst Oswaldo Cruz. 2010;105:422–35. https://doi.org/10.1590/S0074-02762010000400012.CrossRefPubMed

14.

Ross AG, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis. 2007;7:218–24. https://doi.org/10.1016/S1473-3099(07)70053-1.CrossRefPubMed

15.

Ross AGP, Sleigh AC, Li Y, Davis GM, Williams GM, Jiang Z, et al. Schistosomiasis in the People’s Republic of China: Prospects and challenges for the 21st century. Clin Microbiol Rev. 2001;14:270–95. https://doi.org/10.1128/CMR.14.2.270-295.2001.CrossRefPubMedPubMedCentral

16.

Langenberg MCC, Hoogerwerf MA, Janse JJ, van Lieshout L, Corstjens PLAM, Roestenberg M, et al. Katayama syndrome without schistosoma mansoni eggs. Ann Intern Med. 2019;170:732–3. https://doi.org/10.7326/L18-0438.CrossRefPubMed

17.

Gobbi F, Tamarozzi F, Buonfrate D, van Lieshout L, Bisoffi Z, Bottieau E. New insights on acute and chronic schistosomiasis: do we need a redefinition? Trends Parasitol. 2020;36:660–7. https://doi.org/10.1016/j.pt.2020.05.009.CrossRefPubMed

18.

Jauréguiberry S, Paris L, Caumes E. Acute schistosomiasis, a diagnostic and therapeutic challenge. Clin Microbiol Infect. 2010;16:225–31. https://doi.org/10.1111/j.1469-0691.2009.03131.x.CrossRefPubMed

19.

Grandière-Pérez L, Ansart S, Paris L, Faussart A, Jaureguiberry S, Grivois J-P, et al. Efficacy of praziquantel during the incubation and invasive phase of Schistosoma haematobium schistosomiasis in 18 travelers. Am J Trop Med Hyg. 2006;74:814–8.CrossRefPubMed

20.

Rocha MOC, Rocha RL, Pedroso ÊRP, Greco DB, Ferreira CS, Lambertucci JR, et al. Pulmonary manifestations in the initial phase of schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1995;37:311–8. https://doi.org/10.1590/S0036-46651995000400005.CrossRefPubMed

21.

de Jesus AR, Silva A, Santana LB, Magalhães A, de Jesus AA, de Almeida RP, et al. Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. J Infect Dis. 2002;185:98–105. https://doi.org/10.1086/324668.CrossRefPubMed

22.

Epelboin L, Jauréguiberry S, Estève JB, Danis M, Komajda M, Bricaire F, et al. Case report: myocarditis during acute schistosomiasis in two travelers. Am J Trop Med Hyg. 2010;82:365–7. https://doi.org/10.4269/ajtmh.2010.09-0084.CrossRefPubMedPubMedCentral

23.

Bottieau E, Clerinx J, de Vega MR, van den Enden E, Colebunders R, van Esbroeck M, et al. Imported Katayama fever: Clinical and biological features at presentation and during treatment. J Infect. 2006;52:339–45. https://doi.org/10.1016/j.jinf.2005.07.022.CrossRefPubMed

24.

Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. The Lancet. 2006;368:1106–18. https://doi.org/10.1016/S0140-6736(06)69440-3.CrossRef

25.

Hinz R, Schwarz NG, Hahn A, Frickmann H. Serological approaches for the diagnosis of schistosomiasis–A review. Mol Cell Probes. 2017;31:2–21. https://doi.org/10.1016/j.mcp.2016.12.003.CrossRefPubMed

26.

Cnops L, Huyse T, Maniewski U, Soentjens P, Bottieau E, van Esbroeck M, et al. Acute Schistosomiasis with a Schistosoma mattheei × Schistosoma haematobium Hybrid Species in a Cluster of 34 Travelers Infected in South Africa. Clin Infect Dis. 2021;72:1693–8. https://doi.org/10.1093/cid/ciaa312.CrossRefPubMed

27.

Wichmann D, Poppert S, von Thien H, Clerinx J, Dieckmann S, Jensenius M, et al. Prospective European-wide multicentre study on a blood based real-time PCR for the diagnosis of acute schistosomiasis. BMC Infect Dis. 2013;13:55. https://doi.org/10.1186/1471-2334-13-55.CrossRefPubMedPubMedCentral

28.

Hoekstra PT, van Esbroeck M, de Dood CJ, Corstjens PL, Cnops L, et al. Early diagnosis and follow-up of acute schistosomiasis in a cluster of infected Belgian travellers by detection of antibodies and circulating anodic antigen (CAA): A diagnostic evaluation study. Travel Med Infect Dis. 2021;41:102053. https://doi.org/10.1016/j.tmaid.2021.102053.CrossRefPubMed

29.

Sabah AA, Fletcher C, Webbe G, Doenhoff MJ. Schistosoma mansoni: Chemotherapy of infections of different ages. Exp Parasitol. 1986;61:294–303. https://doi.org/10.1016/0014-4894(86)90184-0.CrossRefPubMed

30.

Corachán M. Schistosomiasis in travelers. J Travel Med. 1995;2:1–3.CrossRefPubMed

31.

Harries AD, Cook GC. Acute schistosomiasis (Katayama fever): clinical deterioration after chemotherapy. J Infect. 1987;14:159–61. https://doi.org/10.1016/S0163-4453(87)92002-0.CrossRefPubMed

32.

Corachan M. Schistosomiasis and international travel. Clin Infect Dis. 2002;35:446–50. https://doi.org/10.1086/341895.CrossRefPubMed

33.

Granier H, Potard M, Diraison P, Nicolas X, Laborde JP, Talarmin F. Acute encephalitis concurrent with primary infection by schistosoma mansoni. Med Trop (Mars). 2003;63:60–3.PubMed

34.

Visser LG, Polderman AM, Stuiver PC. Outbreak of schistosomiasis among travelers returning from Mali. West Africa Clin Infect Dis. 1995;20:280–5. https://doi.org/10.1093/clinids/20.2.280.CrossRefPubMed

35.

Roca C, Balanzó X, Gascón J, Fernández-Roure J, Vinuesa T, Valls M, et al. Comparative, clinico-epidemiologic study of schistosoma mansoni infections in travellers and immigrants in Spain. Eur J Clin Microbiol Infect Dis. 2002;21:219–23. https://doi.org/10.1007/s10096-001-0683-z.CrossRefPubMed

36.

Doherty JF, Moody AH, Wright SG. Katayama fever: an acute manifestation of schistosomiasis. BMJ. 1996;313:1071–2. https://doi.org/10.1136/bmj.313.7064.1071.CrossRefPubMedPubMedCentral

37.

Farid Z, Mansour N, Kamal K, Girgis N, Woody J, Kamal M. The diagnosis and treatment of acute toxaemic schistosomiasis in children. Trans R Soc Trop Med Hyg. 1987;81:959. https://doi.org/10.1016/0035-9203(87)90364-6.CrossRefPubMed

38.

Barbosa CS, Montenegro SML, Abath FGC, Domingues ALC. Specific situations related to acute schistosomiasis in Pernambuco. Brazil Mem Inst Oswaldo Cruz. 2001;96:169–72. https://doi.org/10.1590/S0074-02762001000900026.CrossRefPubMed

39.

Vazquez ML, Jung H, Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology. 1987;37:1561–2. https://doi.org/10.1212/wnl.37.9.1561.CrossRefPubMed

40.

Xiao SH, Booth M, Tanner M. The Prophylactic Effects of Artemether against Schistosoma japonicum Infections. Parasitol Today. 2000;16:122–6. https://doi.org/10.1016/S0169-4758(99)01601-4.CrossRefPubMed

41.

Utzinger J, N’Goran EK, N’Dri A, Lengeler C, Shuhua X, Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet. 2000;355:1320–5. https://doi.org/10.1016/S0140-6736(00)02114-0.CrossRefPubMed

42.

Pottie K, Greenaway C, Feightner J, Welch V, Swinkels H, Rashid M, et al. Evidence-based clinical guidelines for immigrants and refugees. Can Med Assoc J. 2011;183:E824-925. https://doi.org/10.1503/cmaj.090313.CrossRef

43.

Chaves NJ, Paxton GA, Biggs B, Thambiran A, Gardiner J, Williams J, et al. The Australasian Society for Infectious Diseases and Refugee Health Network of Australia recommendations for health assessment for people from refugee-like backgrounds: an abridged outline. Med J Aust. 2017;206:310–5. https://doi.org/10.5694/mja16.00826.CrossRefPubMed

44.

Istituto nazionale per la promozione della salute delle popolazioni migranti e per il contrasto delle malattie della povertà. I controlli alla frontiera. La frontiera dei controlli. Controlli sanitari all’arrivo e percorsi di tutela per i migranti ospiti 2017:1–116. www.inmp.it/lg/LG_Migranti-integrata.pdf Accessed 9 Mar, 2019.

45.

ECDC. 2018 Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA. Doi: https://doi.org/10.2900/154411.

46.

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Global Migration and Quarantine. Presumptive Treatment and Screening for Strongyloidiasis, Infections Caused by Other Soil-Transmitted Helminths, and Schistosomiasis among Newly Arrived Refugees 2019. https://stacks.cdc.gov/view/cdc/109513 Accessed 29 Jan 2023.

47.

Migrant Health Assessment Sub-committee of HPSC Scientific Advisory Committee. Infectious Disease Assessment for Migrants 2015:77. https://www.hpsc.ie/a-z/specificpopulations/migrants/guidance/File,14742,en.pdf.

48.

Public Health England. Helminth infections: migrant health guide 2021. https://www.gov.uk/government/publications/pre-entry-health-assessments-guidance-for-uk-refugees Accessed 11 Dec, 2022.

49.

Rahman HU, Khan W, Mehmood SA, Ahmed S, Yasmin S, Ahmad W, et al. Prevalence of cestodes infection among school children of urban parts of Lower Dir district. Pakist Braz J Biol. 2022;82:1–6. https://doi.org/10.1590/1519-6984.242205.CrossRef

50.

Gordon C, Kurscheid J, Williams G, Clements A, Li Y, Zhou X-N, et al. Asian schistosomiasis: current status and prospects for control leading to elimination. Trop Med Infect Dis. 2019;4:40. https://doi.org/10.3390/tropicalmed4010040.CrossRefPubMedPubMedCentral

51.

Rothe C, Zimmer T, Schunk M, Wallrauch C, Helfrich K, Gültekin F, et al. Developing endemicity of schistosomiasis, Corsica. France Emerg Infect Dis. 2021;27:319–21. https://doi.org/10.3201/EID2701.204391.CrossRefPubMed

52.

Bocanegra C, Álvarez-Martínez MJ, Arsuaga Vicente M, Belhassen-García M, Chamorro Tojeiro S, Camprubí-Ferrer D, et al. Executive summary consensus statement of imported diseases group (GEPI) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of tropical medicine and international health (setmsi), on the diagnostic and treatment of imported schistosomiasis. Enferm Infecc Microbiol Clin. 2023. https://doi.org/10.1016/j.eimc.2023.02.004.CrossRef

53.

Centers for Disease Control and Prevention (CDC). Schistosomiasis. https://www.cdc.gov/dpdx/schistosomiasis/index.html accessed 3 May 2022.

54.

Soonawala D, van Lieshout L, den Boer MAM, Claas ECJ, Verweij JJ, Godkewitsch A, et al. Post-travel screening of asymptomatic long-term travelers to the tropics for intestinal parasites using molecular diagnostics. Am J Trop Med Hyg. 2014;90:835–9. https://doi.org/10.4269/ajtmh.13-0594.CrossRefPubMedPubMedCentral

55.

Andrade JR, Silva LD, Guimaraes CM, Bassetti-Soares E, Cambraia RD, Couto OFM, et al. Chronic hepatitis B and liver schistosomiasis: a deleterious association. Trans R Soc Trop Med Hyg. 2014;108:159–64. https://doi.org/10.1093/trstmh/tru010.CrossRefPubMed

56.

Abruzzi A, Fried B, Alikhan SB. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses. In: Rollinson D, Stothard JR, (eds). vol. 91, Academic Press; 2016. 111–231.

57.

Soe HZ, Oo CC, Myat TO, Maung NS. Detection of Schistosoma Antibodies and exploration of associated factors among local residents around Inlay Lake, Southern Shan State. Myanmar Infect Dis Poverty. 2017. https://doi.org/10.1186/s40249-016-0211-0.CrossRefPubMed

58.

Bajracharya D, Pandit S, Bhandari D. First case report of Schistosoma japonicum in Nepal. Access Microb. 2020. https://doi.org/10.1099/acmi.0.000117.CrossRef

59.

Webb JA, Fabreau G, Spackman E, Vaughan S, McBrien K. The cost-effectiveness of schistosomiasis screening and treatment among recently resettled refugees to Canada: an economic evaluation. CMAJ Open. 2021;9:E125–33. https://doi.org/10.9778/cmajo.20190057.CrossRefPubMedPubMedCentral

60.

Zammarchi L, Botta A, Tilli M, Gobbi F, Bartoloni A, Boccalini S. Presumptive treatment or serological screening for schistosomiasis in migrants from Sub-Saharan Africa could save both lives and money for the Italian National Health System: results of an economic evaluation. J Travel Med. 2022. https://doi.org/10.1093/jtm/taac140.CrossRefPubMed

61.

Beltrame A, Guerriero M, Angheben A, Gobbi F, Requena-Mendez A, Zammarchi L, et al. Accuracy of parasitological and immunological tests for the screening of human schistosomiasis in immigrants and refugees from African countries: an approach with latent class analysis. PLoS Negl Trop Dis. 2017;11:e0005593.CrossRefPubMedPubMedCentral

62.

Hoekstra PT, Chernet A, de Dood CJ, Brienen EAT, Corstjens PLAM, Labhardt ND, et al. Sensitive diagnosis and post-treatment follow-up of schistosoma mansoni infections in asymptomatic eritrean refugees by circulating anodic antigen detection and polymerase chain reaction. Am J Trop Med Hyg. 2022. https://doi.org/10.4269/ajtmh.21-0803.CrossRefPubMedPubMedCentral

63.

Tamarozzi F, Ursini T, Hoekstra PT, Silva R, Costa C, Gobbi F, et al. Evaluation of microscopy, serology, circulating anodic antigen (CAA), and eosinophil counts for the follow-up of migrants with chronic schistosomiasis: a prospective cohort study. Parasit Vectors. 2021;14:1–11. https://doi.org/10.1186/s13071-021-04655-z.CrossRef

64.

Beltrame A, Zammarchi L, Zuglian G, Gobbi F, Angheben A, Marchese V, et al. Schistosomiasis screening of travelers from italy with possible exposure in Corsica. France Emerg Infect Dis. 2015;21:1887–9. https://doi.org/10.3201/eid2110.150869.CrossRefPubMed

65.

Agbata E, Morton R, Bisoffi Z, Bottieau E, Greenaway C, Biggs B-A, et al. Effectiveness of screening and treatment approaches for schistosomiasis and strongyloidiasis in newly-arrived migrants from endemic countries in the EU/EEA: A systematic review. Int J Environ Res Public Health. 2018;16:11. https://doi.org/10.3390/ijerph16010011.CrossRefPubMedPubMedCentral

66.

McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev Dis Prim. 2018;4:1–19. https://doi.org/10.1038/s41572-018-0013-8.CrossRef

67.

Ohmae H, Sinuon M, Kirinoki M, Matsumoto J, Chigusa Y, Socheat D, et al. Schistosomiasis mekongi: From discovery to control. Parasitol Int. 2004;53:135–42. https://doi.org/10.1016/j.parint.2004.01.004.CrossRefPubMed

68.

Omar HH. Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives. Hepat Med. 2019;11:131–6. https://doi.org/10.2147/HMER.S155962.CrossRefPubMedPubMedCentral

69.

Barsoum RS. Urinary Schistosomiasis: Review. J Adv Res. 2013;4:453–9. https://doi.org/10.1016/j.jare.2012.08.004.CrossRefPubMed

70.

Jalloh M, Cassell A, Diallo T, Gaye O, Ndoye M, Mbodji MM, et al. Is schistosomiasis a risk factor for bladder cancer? Evid-Based Facts. J Trop Med. 2020. https://doi.org/10.1155/2020/8270810.CrossRefPubMedPubMedCentral

71.

IARC 1994 Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. Schistosomes, liver flukes and Helicobacter pylori. 61:1–241.

72.

Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. The Lancet. 2014;383:2253–64.CrossRef

73.

Hotez PJ, Harrison W, Fenwick A, Bustinduy AL, Ducker C, Sabina Mbabazi P, et al. Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women. PLoS Negl Trop Dis. 2019;13:e0007025. https://doi.org/10.1371/journal.pntd.0007025.CrossRefPubMedPubMedCentral

74.

World Health Organization (WHO). Female genital schistosomiasis: a pocket atlas for clinical health-care professionals 2015. https://apps.who.int/iris/handle/10665/180863.

75.

Sturt A, Webb E, Francis S, Hayes R, Bustinduy A. Beyond the barrier: female genital schistosomiasis as a potential risk factor for HIV-1 acquisition. Acta Trop. 2020;209:105524. https://doi.org/10.1016/j.actatropica.2020.105524.CrossRefPubMedPubMedCentral

76.

Kjetland EF, Kurewa EN, Mduluza T, Midzi N, Gomo E, Friis H, et al. The first community-based report on the effect of genital Schistosoma haematobium infection on female fertility. Fertil Steril. 2010;94:1551–3. https://doi.org/10.1016/j.fertnstert.2009.12.050.CrossRefPubMed

77.

Zirimenya L, Mahmud-Ajeigbe F, McQuillan R, Li Y. A systematic review and meta-analysis to assess the association between urogenital schistosomiasis and HIV/AIDS infection. PLoS Negl Trop Dis. 2020;14:e0008383. https://doi.org/10.1371/journal.pntd.0008383.CrossRefPubMedPubMedCentral

78.

Abdel-Naser MB, Altenburg A, Zouboulis CC, Wollina U. Schistosomiasis (bilharziasis) and male infertility. Andrologia. 2019;51:1–6. https://doi.org/10.1111/and.13165.CrossRef

79.

Kayuni S, Lampiao F, Makaula P, Juziwelo L, Lacourse EJ, Reinhard-Rupp J, et al. A systematic review with epidemiological update of male genital schistosomiasis (MGS): A call for integrated case management across the health system in sub-Saharan Africa. Parasite Epid Cont. 2019. https://doi.org/10.1016/j.parepi.2018.e00077.CrossRef

80.

Feldmeier H, Leutscher P, Poggensee G, Harms G. Male genital schistosomiasis and haemospermia. Trop Med Int Health. 1999;4:791–3. https://doi.org/10.1046/j.1365-3156.1999.00511.x.CrossRefPubMed

81.

Coltart CEM, Chew A, Storrar N, Armstrong M, Suff N, Morris L, et al. Schistosomiasis presenting in travellers: a 15 year observational study at the Hospital for Tropical Diseases, London. Trans R Soc Trop Med Hyg. 2015;109:214–20.CrossRefPubMed

82.

Marchese V, Beltrame A, Angheben A, Monteiro GB, Giorli G, Perandin F, et al. Schistosomiasis in immigrants, refugees and travellers in an Italian referral centre for tropical diseases. Infect Dis Poverty. 2018;7:1–10. https://doi.org/10.1186/s40249-018-0440-5.CrossRef

83.

Tilli M, Gobbi F, Rinaldi F, Testa J, Caligaris S, Magro P, et al. The diagnosis and treatment of urogenital schistosomiasis in Italy in a retrospective cohort of immigrants from Sub-Saharan Africa. Infection. 2019;47:447–59. https://doi.org/10.1007/s15010-019-01270-0.CrossRefPubMed

84.

Belhassen-García M, Pardo-Lledías J, Pérez Del Villar L, Muro A, Velasco-Tirado V, Blázquez De Castro A, et al. Relevance of eosinophilia and hyper-IgE in immigrant children. Medicine. 2014;93:43. https://doi.org/10.1097/MD.0000000000000043.CrossRef

85.

Utzinger J, Becker SL, van Lieshout L, van Dam GJ, Knopp S. New diagnostic tools in schistosomiasis. Clin Microbiol Infect. 2015;21:529–42. https://doi.org/10.1016/j.cmi.2015.03.014.CrossRefPubMed

86.

Weerakoon KGAD, Gobert GN, Cai P, Mcmanus DP. Advances in the diagnosis of human. Schistosomiasis. 2015. https://doi.org/10.1128/CMR.00137-14.CrossRef

87.

WHO. Basic laboratory methods in medical parasitology 1991. https://apps.who.int/iris/handle/10665/40793.

88.

Coulibaly JT, Andrews JR, Lo NC, N’Goran EK, Utzinger J, Keiser J, et al. Schistosoma haematobium egg excretion does not increase after exercise: implications for diagnostic testing. Am J Trop Med Hyg. 2018;98:772–5. https://doi.org/10.4269/ajtmh.17-0728.CrossRefPubMed

89.

Barsoum IS, Colley DG, Kamal KA. Schistosoma mansoni: detection of circulating antigens in murine schistosomiasis by antigen-capture sandwich ELISA using a monoclonal antibody. Exper Parasitol. 1990;71:107.CrossRef

90.

Ochodo EA, Gopalakrishna G, Spek B, Reitsma JB, van Lieshout L, Polman K, et al. Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas. Coch Datab Systemat Rev. 2015. https://doi.org/10.1002/14651858.CD009579.pub2.CrossRef

91.

Neumayr A, Chernet A, Sydow V, Kling K, Kuenzli E, Marti H, et al. Performance of the point-of-care circulating cathodic antigen (POC-CCA) urine cassette test for follow-up after treatment of S. mansoni infection in Eritrean refugees. Travel Med Infect Dis. 2019;28:59–63. https://doi.org/10.1016/j.tmaid.2018.09.004.CrossRefPubMed

92.

van Dam GJ, de Dood CJ, Lewis M, Deelder AM, van Lieshout L, Tanke HJ, et al. A robust dry reagent lateral flow assay for diagnosis of active schistosomiasis by detection of Schistosoma circulating anodic antigen. Exp Parasitol. 2013;135:274–82. https://doi.org/10.1016/j.exppara.2013.06.017.CrossRefPubMedPubMedCentral

93.

Knopp S, Corstjens PLAM, Koukounari A, Cercamondi CI, Ame SM, Ali SM, et al. Sensitivity and specificity of a urine circulating anodic antigen test for the diagnosis of schistosoma haematobium in low endemic settings. PLoS Negl Trop Dis. 2015;9:e0003752. https://doi.org/10.1371/journal.pntd.0003752.CrossRefPubMedPubMedCentral

94.

van Dam GJ, Odermatt P, Acosta L, Bergquist R, de Dood CJ, Kornelis D, et al. Evaluation of banked urine samples for the detection of circulating anodic and cathodic antigens in Schistosoma mekongi and S. japonicum infections: A proof-of-concept study. Acta Trop. 2015;141:198–203. https://doi.org/10.1016/j.actatropica.2014.09.003.CrossRefPubMed

95.

van Grootveld R, van Dam GJ, de Dood C, de Vries JJC, Visser LG, Corstjens PLAM, et al. Improved diagnosis of active Schistosoma infection in travellers and migrants using the ultra-sensitive in-house lateral flow test for detection of circulating anodic antigen (CAA) in serum. Eur J Clin Microbiol Infect Dis. 2018;37:1709–16. https://doi.org/10.1007/s10096-018-3303-x.CrossRefPubMedPubMedCentral

96.

Verweij JJ, Rune SC. Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections. Clin Microbiol Rev. 2014;27:371–418. https://doi.org/10.1128/CMR.00122-13.CrossRefPubMedPubMedCentral

97.

Weerakoon KG, Gordon CA, McManus DP. DNA diagnostics for schistosomiasis control. Trop Med Infect Dis. 2018;3:1–20. https://doi.org/10.3390/tropicalmed3030081.CrossRef

98.

Jones ME, Mitchell RG, Leen CLS. Long seronegative window in schistosoma infection. The Lancet. 1992;340:1549–50. https://doi.org/10.1016/0140-6736(92)92805-P.CrossRef

99.

Bierman WFW, Wetsteyn JCFM, Gool T. Presentation and diagnosis of imported schistosomiasis: relevance of eosinophilia, microscopy for ova, and serology. J Travel Med. 2006;12:9–13.CrossRef

100.

Richter J, Botelho MC, Holtfreter MC, Akpata R, el Scheich T, Neumayr A, et al. Ultrasound assessment of schistosomiasis. Z Gastroenterol. 2016;54:653–60. https://doi.org/10.1055/s-0042-107359.CrossRefPubMed

101.

Castillo-Fernández N, Soriano-Pérez MJ, Lozano-Serrano AB, Sánchez-Sánchez JC, Villarejo-Ordóñez A, Cuenca-Gómez JA, et al. Usefulness of ultrasound in sub-Saharan patients with a serological diagnosis of schistosomiasis. Infection. 2021;49:919–26. https://doi.org/10.1007/s15010-021-01612-x.CrossRefPubMed

102.

Khalaf I, Shokeir A, Shalaby M. Urologic complications of genitourinary schistosomiasis. World J Urol. 2012;30:31–8. https://doi.org/10.1007/s00345-011-0751-7.CrossRefPubMed

103.

Santos J, Chaves J, Araújo H, Vale N, Costa JM, Brindley PJ, et al. Comparison of findings using ultrasonography and cystoscopy in urogenital schistosomiasis in a public health centre in rural Angola. S Afr Med J. 2015;105:312–5. https://doi.org/10.7196/samj.8564.CrossRefPubMed

104.

Richter J, Hatz C, Campagne G, Bergquist NR, Jenkins JM, for Research UBSP, et al. 1996 Ultrasound in schistosomiasis : a practical guide to the standard use of ultrasonography for assessment of schistosomiasis-related morbidity : Second international workshop, Niamey, Niger

105.

Richter J, Correia Dacal AR, Vergetti Siqueira JG, Poggensee G, Mannsmann U, Deelder A, et al. Sonographic prediction of variceal bleeding in patients with liver fibrosis due to Schistosoma mansoni. Tropical Med Int Health. 1998;3:728–35. https://doi.org/10.1046/j.1365-3156.1998.00285.x.CrossRef

106.

Ferreira FG, Ribeiro MA, de Fátima SM, Assef JC, Szutan LA. Doppler ultrasound could predict varices progression and rebleeding after portal hypertension surgery: lessons from 146 EGDS and 10 years of follow-up. World J Surg. 2009;33:2136–43. https://doi.org/10.1007/s00268-009-0196-y.CrossRefPubMed

107.

Ross AGP, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, et al. Schistosomiasis. N Engl J Med. 2002;346:1212–20. https://doi.org/10.1056/NEJMra012396.CrossRefPubMed

108.

Marangoni D. Diagnosi e gestione clinica della schistosomiasi urogenitale complicata: revisione sistematica della letteratura. Univer Flor. 2021;11:455.

109.

Basile G, Tamarozzi F, Salas-Coronas J, Soriano-Pérez MJ, Luzón-García P, Moro L, et al. Management of imported complicated urogenital schistosomiasis in Europe: a TropNet retrospective study. J Travel Med. 2022. https://doi.org/10.1093/jtm/taac150.CrossRef

110.

Tamarozzi F, Ursini T, Ronzoni N, Monteiro GB, Gobbi FG, Angheben A, et al. Prospective cohort study using ultrasonography of Schistosoma haematobium–infected migrants. J Travel Med. 2021;28:1–7. https://doi.org/10.1093/jtm/taab122.CrossRef

111.

Kjetland EF, Leutscher PDC, Ndhlovu PD. A review of female genital schistosomiasis. Trends Parasitol. 2012;28:58–65. https://doi.org/10.1016/j.pt.2011.10.008.CrossRefPubMed

112.

OMS. 2015 Female genital schistosomiasis: A pocket atlas for clinical health-care professionals. Who/Htm/Ntd/20154. 2015:49.

113.

Ross MD, Blair DM, Weber MC, Gelfand M. Distribution and extent of schistosomiasis in female pelvic organs, with special reference to the genital tract, as determined at autopsy. Am J Trop Med Hyg. 1971;20:846–9. https://doi.org/10.4269/ajtmh.1971.20.846.CrossRefPubMed

114.

Shebel HM, Elsayes KM, Abou El Atta HM, Elguindy YM, El-Diasty TA. Genitourinary Schistosomiasis: life cycle and radiologic-pathologic findings. Radiographics. 2012;32:1031–46. https://doi.org/10.1148/rg.324115162.CrossRefPubMed

115.

Harries AD, Walker J, Fryatt R, Chiodini PL, Bryceson ADM. Schistosomiasis in expatriates returning to britain from the tropics: a controlled study. The Lancet. 1986;327:86–8. https://doi.org/10.1016/S0140-6736(86)90730-0.CrossRef

116.

Fenwick A, Savioli L, Engels D, Robert Bergquist N, Todd MH. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 2003;19:509–15. https://doi.org/10.1016/j.pt.2003.09.005.CrossRefPubMed

117.

Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis. 2008;21:659–67. https://doi.org/10.1097/QCO.0b013e328318978f.CrossRefPubMed

118.

Cucchetto G, Buonfrate D, Marchese V, Rodari P, Ferrari A, Zanotti P, et al. High-dose or multi-day praziquantel for imported schistosomiasis? A systematic review J Travel Med. 2019;26:1–9. https://doi.org/10.1093/jtm/taz050.CrossRef

119.

Kramer CV, Zhang F, Sinclair D, Olliaro PL. Drugs for treating urinary schistosomiasis. Coch Datab Syst Rev. 2014. https://doi.org/10.1002/14651858.CD000053.pub3.CrossRef

120.

WHO Expert Committee on the Control of Schistosomiasis. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. World Health Organization 2001.

121.

Biltricide https://resources.bayer.com.au/resources/uploads/pi/file9318.pdf.

122.

Zwang J, Olliaro PL. Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis—a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl Trop Dis. 2014;8:e3286.CrossRefPubMedPubMedCentral

123.

Zwang J, Olliaro P. Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis. Parasit Vect. 2017;10:1–16. https://doi.org/10.1186/s13071-016-1958-7.CrossRef

124.

World Health Organization. WHO Guideline on control and elimination of human schistosomiasis 2022. https://www.who.int/publications/i/item/9789240041608.

125.

Comelli A, Riccardi N, Canetti D, Spinicci M, Cenderello G, Magro P, et al. Delay in schistosomiasis diagnosis and treatment: A multicenter cohort study in Italy. J Travel Med. 2020;27:1–7. https://doi.org/10.1093/jtm/taz075.CrossRef

126.

Gobbi F, Buonfrate D, Angheben A, Beltrame A, Bassetti M, Bertolaccini L, et al. Pulmonary nodules in African migrants caused by chronic schistosomiasis. Lancet Infect Dis. 2017;17:e159–65. https://doi.org/10.1016/S1473-3099(16)30530-8.CrossRefPubMed

127.

King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: A systematic review. PLoS Negl Trop Dis. 2011. https://doi.org/10.1371/journal.pntd.0001321.CrossRefPubMedPubMedCentral

128.

Hoekstra PT, Casacuberta-Partal M, van Lieshout L, Corstjens PLAM, Tsonaka R, Assaré RK, et al. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d’Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST). PLoS Negl Trop Dis. 2020;14:e0008189. https://doi.org/10.1371/journal.pntd.0008189.CrossRefPubMedPubMedCentral

129.

Burchard G, Ehrhardt S, Grobusch M, Junghanss T, Löscher T, Reisinger E, et al. Leitlinie: diagnostik und therapie der schistosomiasis (Bilharziose). AWMF Online Das Portal Der Wissenschaftlichen Medizin. 2013;42:1–36.

130.

Fong GC, Cheung RT. Caution with praziquantel in neurocysticercosis. Stroke. 1997;28:1648–9.CrossRefPubMed

131.

The University of Liverpool HIV Drug Interactions. https://www.hiv-druginteractions.org/checker Accessed 5 May 2023.

132.

Friedman JF, Olveda RM, Mirochnick MH, Bustinduy AL, Elliott AM. Praziquantel for the treatment of schistosomiasis during human pregnancy. Bull World Health Organ. 2018;96:59–65. https://doi.org/10.2471/BLT.17.198879.CrossRefPubMed

133.

World Health Organization. Strategy Development and Monitoring for Parasitic Diseases and Vector Control Team. (2003). Report of the WHO informal consultation on the use of praziquantel during pregnancy/lactation and albendazole/mebendazole in children under 24 months: Geneva, 8–9 April 2002. World Health Organization.

134.

Coulibaly JT, Panic G, Silué KD, Kovač J, Hattendorf J, Keiser J. Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial. Lancet Glob Health. 2017;5:e688–98. https://doi.org/10.1016/S2214-109X(17)30187-0.CrossRefPubMedPubMedCentral

135.

Garba A, Lamine MS, Djibo A, Tahirou A, Aouami MA, Alfari A, et al. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger. Acta Trop. 2013;128:318–25. https://doi.org/10.1016/j.actatropica.2012.12.003.CrossRefPubMed

136.

N’Goran EK, Yalkinoglu Ö, Kourany-Lefoll E, Tappert A, Hayward B, Yin X, et al. Efficacy and safety of new orodispersible tablet formulations of praziquantel (racemate and l-praziquantel) in schistosoma mansoni-infected preschool-age children and infants: a randomized dose-finding phase 2 study. Front Trop Dis. 2021. https://doi.org/10.3389/fitd.2021.679373.CrossRef

137.

Tamarozzi F, Fittipaldo VA, Orth HM, Richter J, Buonfrate D, Riccardi N, et al. Diagnosis and clinical management of hepatosplenic schistosomiasis: a scoping review of the literature. PLoS Negl Trop Dis. 2021;15:e0009191. https://doi.org/10.1371/journal.pntd.0009191.CrossRefPubMedPubMedCentral

138.

Ede CJ, Nikolova D, Brand M. Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis. Coch Datab System Rev. 2018. https://doi.org/10.1002/14651858.CD011717.pub2.CrossRef

139.

el Tourabi H, el Amin AA, Shaheen M, Woda SA, Homeida M, Harron DWG. Propranolol reduces mortality in patients with portal hypertension secondary to schistosomiasis. Ann Trop Med Parasitol. 1994;88:493–500. https://doi.org/10.1080/00034983.1994.11812896.CrossRefPubMed

140.

Nordmann T, Schlabe S, Feldtid T, Gobbi F, Krieg A, Bode JG, et al. TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis–A case series and review of the literature. PLoS Negl Trop Dis. 2021;15:1–15. https://doi.org/10.1371/journal.pntd.0010065.CrossRef

141.

Kho S, Andries B, Poespoprodjo JR, Commons RJ, Shanti PAI, Kenangalem E, et al. High risk of plasmodium vivax malaria following splenectomy in Papua. Ind Clin Infect Dis. 2019;68:51–60. https://doi.org/10.1093/cid/ciy403.CrossRef

142.

Bedwani R, Renganathan E, el Kwhsky F, Braga C, Abu Seif HH, Abul Azm T, et al. Schistosomiasis and the risk of bladder cancer in Alexandria. Egypt Br J Cancer. 1998;77:1186–9. https://doi.org/10.1038/bjc.1998.197.CrossRefPubMed

143.

Zaghloul MS, Zaghloul TM, Bishr MK, Baumann BC. Urinary schistosomiasis and the associated bladder cancer: update. J Egypt Natl Canc Inst. 2020. https://doi.org/10.1186/s43046-020-00055-z.CrossRefPubMed

144.

Wishahi MM, Ismail IMH, Ruebben H. Otto thomas. bladder cancer: Keyhole-Limpet Hemocyanin Immunotherapy in the Bilharzial Bladder: a new treatment modality? Phase II trial: superficial bladder cancer. J Urol. 1995;153:926–8. https://doi.org/10.1016/S0022-5347(01)67605-5.CrossRefPubMed

145.

Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of tumours of the urinary system and male genital organs—part b: prostate and bladder tumours. Eur Urol. 2016;70:106–19. https://doi.org/10.1016/j.eururo.2016.02.028.CrossRefPubMed

146.

Aly MS, Khaled HM, Emara M, Hussein TD. Cytogenetic profile of locally advanced and metastatic schistosoma-related bladder cancer and response to chemotherapy. Cancer Genet. 2012;205:156–62. https://doi.org/10.1016/j.cancergen.2012.01.011.CrossRefPubMed

147.

Mohyelden K, Hussein HA, el Helaly HA, Ibrahem H, Abdelwahab H. Long-term outcomes of two ipsilateral vs single double-j stent after laser endoureterotomy for bilharzial ureteral strictures. J Endourol. 2021;35:775–80. https://doi.org/10.1089/end.2020.0956.CrossRefPubMed

148.

Ravi G, Motalib MA. surgical. correction of bilharzial ureteric stricture by boari flap technique. Br J Urol. 1993;71:535–8. https://doi.org/10.1111/j.1464-410X.1993.tb16021.x.CrossRefPubMed

149.

Coltart C, Whitty CJ. Schistosomiasis in non-endemic countries. Clin Med. 2015;15:67–9. https://doi.org/10.7861/clinmedicine.15-1-67.CrossRef

150.

Cavalcanti MG, Cunha AFA, Peralta JM. The advances in molecular and new Point-Of-Care (POC) diagnosis of schistosomiasis pre- and post-praziquantel use; in the pursuit of more reliable approaches for low endemic and non-endemic areas. Front Immunol. 2019;10:1–10. https://doi.org/10.3389/fimmu.2019.00858.CrossRef

151.

Rabello ALT, Garcia MMA, Pinto da Silva RA, Rocha RS, Katz N. humoral immune responses in patients with acute schistosoma mansoni infection who were followed up for two years after treatment. Clin Infect Dis. 1997;24:304–8. https://doi.org/10.1093/clinids/24.3.304.CrossRefPubMed

152.

Whitty CJM, Mabey DC, Armstrong M, Wright SG, Chiodini PL. Presentation and outcome of 1107 cases of schistosomiasisfrom Africa diagnosed in a non-endemic country. Trans R Soc Trop Med Hyg. 2000;94:531–4.CrossRefPubMed

153.

Yong MK, Beckett CL, Leder K, Biggs BA, Torresi J, O’Brien DP. Long-term follow-up of schistosomiasis serology post-treatment in Australian Travelers and Immigrants. J Travel Med. 2010;17:89–93.CrossRefPubMed

154.

Corstjens PLAM, de Dood CJ, Kornelis D, Tjon Kon Fat EM, Wilson RA, Kariuki TM, et al. Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels. Parasitology. 2014;141:1841–55. https://doi.org/10.1017/S0031182014000626.CrossRefPubMed

155.

Sousa MS, van Dam GJ, Pinheiro MCC, de Dood CJ, Peralta JM, Peralta RHS, et al. Performance of an Ultra-Sensitive Assay Targeting the Circulating Anodic Antigen (CAA) for Detection of Schistosoma mansoni Infection in a Low Endemic Area in Brazil. Front Immunol. 2019. https://doi.org/10.3389/fimmu.2019.00682.CrossRefPubMedPubMedCentral

156.

Guegan H, Fillaux J, Charpentier E, Robert-Gangneux F, Chauvin P, Guemas E, et al. Real-time PCR for diagnosis of imported schistosomiasis. PLoS Negl Trop Dis. 2019;13:e0007711. https://doi.org/10.1371/journal.pntd.0007711.CrossRefPubMedPubMedCentral

157.

Richter J. Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: A review of ultrasonographic studies. Acta Trop. 2000;77:111–31. https://doi.org/10.1016/S0001-706X(00)00125-X.CrossRefPubMed

158.

Barda B, Coulibaly JT, Hatz C, Keiser J. Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial. PLoS Negl Trop Dis. 2017;11:1–13. https://doi.org/10.1371/journal.pntd.0005400.CrossRef

159.

Hatz CF, Vennervald BJ, Nkulila T, Vounatsou P, Kombe Y, Mayombana C, et al. Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Amer J Trop Med Hyg. 1998;59:775–81. https://doi.org/10.4269/ajtmh.1998.59.775.CrossRef

160.

Akpata R, Neumayr A, Holtfreter MC, Krantz I, Singh DD, Mota R, et al. The WHO ultrasonography protocol for assessing morbidity due to Schistosoma haematobium. Acceptance and evolution over 14 years. Syst rev Parasitol Res. 2015;114:1279–89.CrossRef

161.

Da Silva IM, Thiengo R, Conceição MJ, Rey L, Pereira Filho E, Ribeiro PC. Cystoscopy in the diagnosis and follow-up of urinary schistosomiasis in Brazilian soldiers returning from Mozambique, Africa. Rev Inst Med Trop Sao Paulo. 2006;48:39–42. https://doi.org/10.1590/s0036-46652006000100008.CrossRefPubMed

Title: Schistosomiasis in non-endemic areas: Italian consensus recommendations for screening, diagnosis and management by the Italian Society of Tropical Medicine and Global Health (SIMET), endorsed by the Committee for the Study of Parasitology of the Italian Association of Clinical Microbiologists (CoSP-AMCLI), the Italian Society of Parasitology (SoIPa), the Italian Society of Gastroenterology and Digestive Endoscopy (SIGE), the Italian Society of Gynaecology and Obstetrics (SIGO), the Italian Society of
Authors: Agnese Comelli
Camilla Genovese
Federico Gobbi
Gaetano Brindicci
Susanna Capone
Angela Corpolongo
Verena Crosato
Valentina Dianora Mangano
Rosalia Marrone
Maria Merelli
Marco Prato
Carmen Rita Santoro
Salvatore Scarso
Elisa Vanino
Valentina Marchese
Spinello Antinori
Claudio Mastroianni
Annibale Raglio
Fabrizio Bruschi
Andrea Minervini
Daniele Donà
Silvia Garazzino
Luisa Galli
Andrea Lo Vecchio
Andrea Galli
Gabriele Dragoni
Claudio Cricelli
Nicola Colacurci
Enrico Ferrazzi
Annalisa Pieralli
Antonio Montresor
Joachim Richter
Guido Calleri
Alessandro Bartoloni
Lorenzo Zammarchi
Publication date: 07-07-2023
Publisher: Springer Berlin Heidelberg
Keywords: Schistosomiasis
Helminths
Colposcopy
Colposcopy
Published in: Infection / Issue 5/2023
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-023-02050-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2023

Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept

Inflammatory ratios for mortality prediction in community acquired pneumonia

Efficacy of pre-exposure prophylaxis to prevent SARS-CoV-2 infection after lung transplantation: a two center cohort study during the omicron era

SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022

The ratio of neutrophil-to-lymphocyte and platelet-to-lymphocyte and association with mortality in community-acquired pneumonia: a derivation-validation cohort study

Diagnosis and management of complicated urogenital schistosomiasis: a systematic review of the literature

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials